Skip To Main Content
Bárbara Bassani on Muck Rack

Bárbara Bassani

As seen in: Nature, MDPI, BioRxiv, Consultor Jurídico, eCancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bárbara

Contact Bárbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Biomarkers of cancer angioprevention for clinical studies

|
By Adriana Albini, Francesco Bertolini, Bárbara Bassani
| eCancer Verified
How likely is this article to improve patient care in your region? Is reading this article likely to improve your clinical practice? How likely are you to recommend this article to a colleague?
Open in Who Shared Issue with article?

The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization

|
By Martina Cucchiara, Maria Teresa Palano, Cristian Rubuano, Gianluca De Antoni, Matteo Gallazzi, Daniele Mercatelli, Marta Tagliabue, Maria Gemelli, Pier Francesco Ferrucci, Gennaro Nappo, Silvia Uccella, Alessandro Zerbi, Patrizia Borsotti, Nicolò Baranzini, Annalisa Grimaldi, Lorenzo Mortara, Francesco Acquati, Paola Muti, Bárbara Bassani, Antonino Bruno, Adelaide Pessi, Gianpiero Catalano, Riccardo Ricotta, Giulia Garattini, Federica Di Leva, Dorina Belotti, Andrea Resovi
| Nature Verified
Abstract Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related mortality worldwide. Natural Killer (NKs) cells are pivotal for tumor surveillance but are dysfunctional in PDAC. We evaluated whether pharmacological blockade of TGF-β1/TGF-βR1 axis in PDAC cells and cancer-associated fibroblasts (CAFs) could modulate NK polarization via soluble factors.
Open in Who Shared Issue with article?

MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces

|
By Davide Barbagallo, Donatella Ponti, Bárbara Bassani, Antonino Bruno
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?
See all 6 articles